The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center
Our real-world experience of an early-adopter center confirms that MRL treatments are feasible for different tumor entities in several anatomical sites. We showed that most of the patients could be treated within 40 min and showed low toxicity rates. Protocols for dose escalation and margin reduction, by adopting new comprehensive motion monitoring strategies, are under development.
Authors
- Andrea Romei (ORCID: https://orcid.org/0009-0005-5831-1826)
- Filippo Alongi (ORCID: https://orcid.org/0000-0002-6569-8628)
- Davide Gurrera (ORCID: https://orcid.org/0000-0001-6138-3621)
- Chiara De‐Colle (ORCID: https://orcid.org/0000-0003-4693-2148)
- Antonio De Simone (ORCID: https://orcid.org/0000-0003-2003-6097)
- Andrea Gaetano Allegra (ORCID: https://orcid.org/0000-0001-6109-4563)
- S. Naccarato (ORCID: https://orcid.org/0000-0001-8440-0906)
- Luca Nicosia (ORCID: https://orcid.org/0000-0002-0731-8041)
- Niccolò Giaj‐Levra
- Carolina Orsatti
- Edoardo Pastorello
- Francesco Ricchetti (ORCID: https://orcid.org/0000-0002-4307-3440)
- Ruggero Ruggieri (ORCID: https://orcid.org/0000-0002-2044-8035)
- G. Sicignano
- Riccardo Filippo Borgese
- Michele Rigo (ORCID: https://orcid.org/0000-0002-0645-0251)
- N. Bianchi
Institutions
- Ospedale Sacro Cuore Don Calabria (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-06-17
- DOI
- https://doi.org/10.3390/cancers17122012
- Citations
- 2
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 3.77